Significant improvement of portopulmonary hypertension after 1-week terlipressin treatment

Journal of Hepatology

Volumn 48, Issue 4, 2008, Pages 678-680

  Kalambokis, Georgios ^a   Korantzopoulos, Panagiotis ^a   Nikas, Spyros A ^a   Theodorou, Areti ^a   Tsianos, Epameinondas V ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Cirrhosis; Portopulmonary hypertension; Terlipressin

Indexed keywords

BOSENTAN; ENDOTHELIN RECEPTOR ANTAGONIST; FUROSEMIDE; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN; TERLIPRESSIN;

ADULT; ARTERIAL OXYGEN SATURATION; ARTICLE; CASE REPORT; CLINICAL FEATURE; HUMAN; KIDNEY FAILURE; LABORATORY TEST; LIVER CIRRHOSIS; MALE; PORTOPULMONARY HYPERTENSION; PRIORITY JOURNAL;

ADULT; ANTIHYPERTENSIVE AGENTS; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, PORTAL; HYPERTENSION, PULMONARY; INJECTIONS, INTRAVENOUS; LYSINE VASOPRESSIN; MALE; SHOCK, SEPTIC; TIME FACTORS;

EID: 39849087833     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.12.012     Document Type: Article

References (18)

1. Krowka M.J. Evolving dilemmas and management of portopulmonary hypertension. Semin Liver Dis 26 (2006) 265-272
2. Budhiraja R., and Hassoun P.M. Portopulmonary hypertension. A tale of two circulations. Chest 123 (2003) 562-576
3. Altintas E., Akkus N., Gen R., Helvaci M.R., Sezgin O., and Oguz D. Effects of terlipressin on systolic pulmonary artery pressure of patients with liver cirrhosis. World J Gastroenterol 10 (2004) 2278-2280
4. Selton-Suty C., Popovic B., Freysz L., Chodek A., Chabot F., and Juilliere Y. Interest of echocardiography in pulmonary arterial hypertension. Ann Cardiol Angeiol (Paris) 56S3 (2007) S112-S122
5. Wong F., Moore K., Dingemanse J., and Jalan R. Lack of renal improvement with nonselective endothelin antagonism with tezosentan in type 2 hepatorenal syndrome. Hepatology 47 (2008) 160-168
6. Wang Y.W., Lin H.C., Yang Y.Y., Hou M.C., and Lee S.D. Sildenafil decreased pulmonary arterial pressure but may have exacerbated portal hypertension in a patient with cirrhosis and portopulmonary hypertension. J Gastroenterol 41 (2006) 593-597
7. Moreau R., and Lebrec D. Diagnosis and treatment of acute renal failure in patients with cirrhosis. Best Pract Res Clin Gastroenterol 21 (2007) 111-123
8. Moreau R., Durand F., Poynard T., Duhamel C., Cervoni J.P., Ichai P., et al. Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study. Gastroenterology 122 (2002) 923-930
9. Tahara A., Tomura Y., Wada K., Kusayama T., Tsukada J., Ishii N., et al. Characterization of vasopressin receptor in rat lung. Neuropepetides 32 (1998) 281-286
10. Fay M.J., Du J., Yu X., and North W.G. Evidence of expression of vasopressin V2 receptor mRNA in human lung. Peptides 17 (1996) 477-481
11. Evora P.R.B., Pearson P.J., and Schaff H.V. Arginine vasopressin induces endothelium-dependent vasodilatation of the pulmonary artery. V1-receptor mediated production of nitric oxide. Chest 103 (1993) 1241-1245
12. Lin H.C., Tsai Y.T., Lee F.Y., Chang T.T., Wang S.S., Lay C.S., et al. Systemic and portal hemodynamic changes following triglycyllysine vasopressin plus nitroglycerin administration in patients with hepatitis B-related cirrhosis. J Hepatol 10 (1990) 370-374
13. Valla D., Lee S.S., Moreau R., Hadengue A., Sayegh R., and Lebrec D. Effects of glypressin on the splanchnic and systemic circulation in patients with cirrhosis. Gastroenterol Clin Biol 9 (1985) 877-880
14. Price L.C., Forrest P., Sodhi V., Adamson D.L., Nelson-Piercy C., Lucey M., et al. Use of vasopressin after caesarean section in idiopathic pulmonary arterial hypertension. Br J Anaesth 99 (2007) 552-555
15. Jin H.K., Chen Y.F., Yang R.H., McKenna T.M., Jackson R.M., and Oparil S. Vasopressin lowers pulmonary arterial pressure in hypoxic rats by releasing atrial natriuretic peptide. Am J Med Sci 298 (1989) 227-236
16. Eichinger M.R., and Walker B.R. Enhanced pulmonary arterial dilation to arginine-vasopressin in chronically hypoxic rats. Am J Physiol 267 (1994) H2413-H2419
17. Selimovic N., Rundqvist B., Bergh C.H., Andersson B., Petersson S., Johansson L., et al. Assessment of pulmonary vascular resistance by Doppler echocardiography in patients with pulmonary arterial hypertension. J Heart Lung Transplant 26 (2007) 927-934
18. Scapellato F., Temporelli P.L., Eleuteri E., Corra U., Imparato A., and Giannuzzi P. Accurate noninvasive estimation of pulmonary vascular resistance by Doppler echocardiography in patients with chronic heart failure. J Am Coll Cardiol 37 (2001) 1813-1819